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 Pain is the leading cause of Emergency Department (ED) visits making it one of the 
primary concerns of the emergency medical field. The experience of pain is subjective and 
unique to every individual making it difficult to effectively manage. As a result, the subjective 
nature of pain is also commonly associated with drug-seekers often claiming to have pain simply 
to receive narcotics to support their addiction. There have been numerous studies completed to 
determine how to effectively recognize drug-seeking.  This integrative literature review will 
identify the common behaviors that have been seen as indicators of drug-seeking in the ED. The 
evidence collected from articles published between 2001 and 2011 examined the use of 
assessment tools, drug screening, and prescription monitoring programs for distinguishing drug-
seekers. The evidence did not identify a specific evaluation tool used to recognize drug-seekers; 
however, the research did suggested that using these techniques can help to identify drug-seeking 
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The most commonly reported symptom upon arrival in Emergency Departments (ED) is 
pain, accounting for approximately 78% of all ED visits (Todd, Ducharme, Choiniere, Crandall, 
& Fosnocht, 2007). Pain associated with an injury accounts for less than one-third of ED visits. 
Clients most commonly complain of pain in the back, neck, abdomin, head, chest, or from an 
unidentifiable source (Todd et al., 2007). Pain is initially classified as acute or chronic. Acute 
pain occurs suddenly, often as the result of injury or illness; whereas, chronic pain persists over a 
longer period of time. It has been estimated that one in three Americans will eventually suffer 
from chronic pain due to illness or injury (Thomas, 2007). Over 50 million Americans across the 
country report chronic back pain, migraine headaches, or arthritis pain on a regular basis making 
pain a major medical problem (Thomas, 2007).  
One of the common goals in the ED is to effectively manage pain symptoms in order to 
alleviate the discomfort experienced by clients (Todd, et al., 2007). Since the implementation of 
the Emergency Medical Treatment and Active Labor Act (EMTALA), EDs have been required 
by law to provide care if any emergency medical condition (EMC) is present including severe 
pain with an unknown source. Severe pain is considered an EMC and must be effectively 
managed in the ED to alleviate symptoms. Regulations set forth by The Joint Commission on 
Accreditation of Healthcare Organization (JCAHO) state that the hospital is responsible for 
managing pain symptoms, and if the hospital is no longer able to meet the needs of the client, the 





Pain is often a symptom of an illness or disease that cannot be directly observed by health 
care providers, therefore possibly leading to a less sympathetic environment (Wilsey, Fishman, 
Ogden, Tsodikov, & Bertakis, 2008b). Clinical manifestations of pain present uniquely in every 
individual depending on a variety of factors including culture, age, gender, and socioeconomic 
status. Clients frequently complain of pain symptoms in areas where objectively assessing an 
etiology is difficult, such as headache, back and neck pain, or abdominal pain (Todd, et al., 
2007).  
If pain is a result of an unidentifiable source, health care providers manage pain 
symptoms with little objective data making it difficult for some health care providers to remain 
compassionate for clients leading to inadequate pain management. Unsatisfactory pain 
management occurs for a variety of reasons including knowledge deficit regarding chronic pain 
management and ethical dilemmas (Pines & Hollander, 2008). Unfortunately, a common reason 
for inadequate pain management is an unwillingness to believe the client’s report of pain (Silka, 
Roth, Moreno, Merrill, & Geiderman, 2004). Improper pain management causes unnecessary 
suffering and results in more than $100 billion in preventable medical expenses from longer 
hospital stays, re-hospitalizations, and recurrent ED visits (Dorsey, Malone, & Simopoulos, 
2009). One of the most prevalent challenges in providing effective pain management in the ED is 
the inability to differentiate drug-seekers from legitimate clients experiencing pain (Hansen, 
2005). A contributing factor to this problem is that screening tools to distinguish drug-seekers 
from clients in pain are not widely used (Dorsey, Malone, & Simopoulos, 2009). This failure to 
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separate drug-seekers from clients with legitimate pain means clients in pain may be mistaken 
for drug-seekers while drug-seekers may be prescribed narcotics.  
A recent article published in the Emergency Department Legal Letter (2009) states that 
for every 75,000 clients seen in an ED every year 5,764 of them are drug-seekers. This implies 
that approximately one in every 13 clients seen in the ED is a drug abuser seeking prescription 
pain medication (Dorsey, Malone, & Simopoulos, 2009). As a result of widespread narcotic 
abuse, medical professionals have developed a defensive approach in order to comply with 
regulations and avoid law suits. Medical professionals with a defensive approach to pain 
management will medicate all clients suffering from pain which may include drug-seekers 
(Baehren, Marco, Droz, Sinha, & Callan, 2010).  
Narcotics are commonly used to treat severe pain from both chronic and acute sources 
and may elicit a euphoric sensation while controlling pain effectively (Wilsey, et al., 2008b). As 
a result of the rapid-onset of narcotics in the central nervous system, they are also associated 
with a high incidence of addictive properties after prolonged use (Hansen, 2005). Narcotics are 
extremely effective for minimizing severe pain; however, due to the highly addictive properties, 
medical providers are often reluctant to use them consistently. When narcotics are used to 
suppress the symptoms of pain, addiction occurs in a small fraction of clients. These clients may 
then seek out narcotics even when there is no longer a physical need for pain relief (Braden, 
Russo, Fan, Edlund, Martin, & DeVries, 2010). Clients will often mimic or feign signs and 
symptoms associated with their previous condition in an attempt to receive narcotics to support 
their addiction (Chan & Winegard, 2007). The lack of adequate evidenced-based screening tools 
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to identify drug-seeking behavior, in combination with drug-seeking in EDs, has been directly 
associated with ineffective emergency pain management (Wilsey, et al., 2008b). 
Purpose 
 The purpose of this integrative literature review is to identify common drug-seeking 
behaviors exhibited by clients in EDs, in an attempt to minimize health care provider 
uncertainties when managing pain symptoms in clients presenting to the ED complaining of 
acute and/or chronic pain. 
Method 
An extensive literature review was completed to identify current assessment tools that are 
being used to identify drug-seeking behaviors, as well as what drug seeking behaviors have 
already been established. The current research available was retrieved from the following 
databases: Cochrane Database of Systematic Reviews, Cumulative Index to Nursing and Allied 
Literature (CINAHL), PubMed, and PsycINFO. Studies were limited to peer-reviewed research 
published in English between January, 2001 and June, 2011. The comprehensive literature search 
was narrowed using keywords including: drug seekers, emergency department, emergency room, 
pain, pain control, pain management, prescription monitoring and substance abusers.   
In order to be included in this review, articles had to meet the following criteria: 
participants were 18 years and older admitted to the emergency department complaining of pain; 
reporting identifiable behaviors exhibited by drug-seekers; address misconceptions associated 
with non-cancer chronic pain; or be directly related to the key terms used to complete the search. 
Furthermore, articles examining the use of pain scales in the ED as well as articles that contained 
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research about the use of drug-seeking evaluations were reviewed. Articles were excluded if pain 
was secondary to a disease process or used animals as their experimental sample.  
Several studies were included to provide a basic knowledge of drug-seeking behaviors 
most commonly seen in the ED.  Multiple studies were used to provide background and 
introductory information to establish the defining characteristics of drug-seekers, substance 
abusers, and common behaviors associated with drug-seeking in the ED. For this integrative 
review of research, twelve total studies met all criteria to identify common drug-seeking 
behaviors associated with substance abuse. Of those studies, ten were quasi-experimental and 
used convenience sampling; whereas the additional two studies were experimental and used 
randomized sampling.  
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Table 1: Literature Search Strategy 
Database Date  Search   Number of   Number of Searched  
  of Search  Strategy   Articles Found         Relevant Articles 
Cochrane 11/03/2010 “Pain Management”  116   1 
    or “Pain Control” and  
    “Drug Seek*” or “Drug 
    Abuse*”      
 
EBSCO 11/01/10 “Emergency   288   11 
CINAHL     Department” and  
   “Pain” 
     
    “Emergency Room”  28   4 
    and “Pain”  
       
 “Pain” and    30   2 
“Drug Seek*” 
 
PubMed 11/03/10 “Emergency 42 5 
 Department 
 and “Pain” and  
 “Drug Seek*”  
 
  11/01/10 “Pain”  110 6 
  and “Drug Seek*”  
 
  “Emergency  288 13 
  Department” and  
  Pain Management” 
  Or “Pain Control” 
  And “Drug Seek*” 
 
11/06/10          “Emergency                           307                               5 
                         Department” and  
                         “Substance Abuse*” 
                         Or “Drug Seek*” 
                         
 01/05/11  “Prescription Monitor*” 304 3 
  and “Substance Abuse*”  
  or “Drug Seek*”  
 
PsycINFO 11/07/10 “Pain Management” 18 3 




Prescription opioid abuse is the intentional misuse of prescription opioids in a manner 
that is not consistent with the way in which the prescribed medication was intended to be used. 
Prescription medication is becoming a more commonly abused substance which has lead to an 
increase in the number of ED visits related to nonmedical use of opioids (White, Birnbaum, 
Schiller, Tang, & Katz, 2009). As a result of the increase in prescription substance abuse, it is 
necessary to identify clients that are drug-seeking. The most common drug-seeking behaviors 
have been associated with complaining of pain that is not validated by diagnostic evidence, 
indicating a medication of preference or stating allergies to specific medication(s), visiting 
multiple EDs, and having a mental health cormobidity in conjunction with prescription abuse 
(Schuckman, Hazelett, Powell, & Steer, 2008; Wilsey, Fishman, Ogden, Tsodikov, & Bertakis, 
2008a; Wilsey et al.,2008b). In addition to identifying common behaviors, it is also important for 
ED care providers to recognize that stereotyping of drug-seekers in the ED minimizes effective 
pain management (Kelleher & Cotter, 2009). 
Pain Source 
 Drug-seekers will often complain of back pain, neck pain, dental pain, or migraine 
headaches because these sources of pain are difficult to validate with diagnostic procedures 
commonly used in the ED. Due to high client ratios in the ED it has been shown to be more 
efficient to refer clients to their primary care provider for diagnostic procedures such as 
computerized axial tomography scans (CT scan), magnetic resonance imaging (MRI), and x-ray 
images unless there is a traumatic event or acute onset of back pain, neck pain, dental pain, or 
migraine headaches (Thomas, 2007). With the chance of practitioners having difficulty in 
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definitively identifying the source of pain related to these complaints, drug-seekers have learned 
that reporting these forms of pain in the ED warrant treatment with strong pain reliving 
medications. In many cases clients with chronic back pain, neck pain, or migraine headaches will 
not have diagnostic evidence to support their pain symptoms which is why drug-seekers often 
mimic these conditions to receive strong narcotics in the ED (White, et al., 2009).   
The objective signs and symptoms of chronic pain include, but are not limited to: 
agitation, facial grimacing, elevated blood pressure, guarding, and restlessness. However, clients 
with true chronic pain can adapt to pain over time and may show very minimal objective signs of 
pain making identifying drug-seekers from clients with chronic pain even more difficult 
(Hawkins, Smeeks, & Hamel, 2008).   
Medication Selecting 
 A common behavior associated with drug-seeking is when clients will identify a 
medication of choice or state that they have allergy to a specific medication which leaves the 
physician with no other alternative but to prescribe a specific class of medication (Schuckman, 
Hazelett, Powell, & Steer, 2008). When a client states they have an allergy to a medication, that 
medication must at all cost be avoided to prevent a dangerous allergic reaction. As such, drug-
seekers use this to their advantage to obtain their drug of choice. The most commonly reported 
allergies associated with drug-seekers include: morphine, codeine, and non-steroidal anti-
inflammatory drugs (NSAIDs). Whereas, the most common substances requested by clients 
suspected of drug-seeking consist of narcotics and benzodiazepines (McNabb, Foot, Ting, 
Breeze, & Stickley, 2006).  
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Hospital Shopping  
 Drug-seekers will often abuse the system by hospital shopping. The term “hospital 
shopping” is used to describe the method that drug-seekers use to obtain medications from 
several sources by going to multiple medical facilities within their surrounding area (Schuckman, 
et al., 2008). As a way to limit the likelihood of being categorized as a drug abuser, individuals 
will visit multiple hospitals to obtain narcotics and decrease the number of visits on record at 
each facility. Visiting multiple facilities is done in an effort to make it appear as though they visit 
the ED on rare occasions, when in reality they are frequently seen in an ED. This is a technique 
that mimics clients suffering from break through pain. Break through pain is a sudden increase in 
chronic pain that cannot be treated with a normal pain management regimen. Chronic pain 
clients will often seek care at the hospital in their area which they choose based on comfort, 
familiarity, and personal standards of care. Drug-seekers will use this knowledge to their 
advantage to make it appear as though they are a chronic pain client with break through pain 
(Baehren et al., 2009). 
Mental Heath  
 Several research studies show that psychiatric illnesses are commonly seen in drug-
seekers. Over 50% of the mentally ill suffer from a history of substance abuse including the use 
of prescription medications (Wilsey, et al., 2008b). It is unclear what the ratio of drug-seekers 
with a mental illness is; however, recent studies have shown that there is a high prevalence in 
drug-seekers with mental health cormobidities. In a study conducted by Barth Wilsey and his 
associates, 113 participants underwent an extensive interview which showed that participants 
suffering from anxiety, depression, personality disorders, and post traumatic stress disorder had a 
10 
 
greater propensity for abusing prescription medications. The research shows that clients with a 
history of mental illness should be evaluated for drug-seeking and vice versa (Wilsey, et al., 
2008b).  
Stereotyping 
 One barrier to properly identifying substance abuse in the ED is practitioner stereotyping 
of clients as drug-seekers (Kelleher & Cotter, 2009). It is possible for ED staff to become 
impartial to clients whom they suspect of drug-seeking. Most ED care providers also recognize 
commonalities in clients whom they suspect of drug-seeking which has lead to biases not as a 
negative correlation but as a result of experience (Kelleher & Cotter, 2009). It is important for 
the ED staff to recognize profiling as an issue and how it can hinder the care provided.  
ED staff work in a state of constant stress and client lives are frequently at risk. Clients 
presenting with pain complaints without objective assessment etiology are at risk for being 
stereotyped as a drug-seeker. When this occurs, it may lead to improper care with up to 8% of 
clients suffering from true pain being categorized as drug-seekers (Dorsey, Malone, & 
Simopoulos, 2009). It is important that ED providers recognize the possibility of stereotyping 
and treat clients properly.  
Summary  
The research shows evidence that there are identifiable drug-seeking behaviors in the ED 
(Dorsey, Malone, & Simopoulos, 2009). Taking into consideration the negative impact that drug-
seeking has on the medical field, such as: drug-seekers take advantage of the medical system, use 
vital resources, and make treatment for clients with chronic pain more difficult, it is important to 
identify drug-seekers and provide the appropriate treatment to decrease the effects that drug-
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seekers have on the emergency medical field. The research indicates that behaviors associated 
with drug-seeking are common in the majority of drug-seekers which shows that there are 
definitive ways to identify this problem and reduce prescription drug abuse in the ED (Butler et 
al., 2007). It is common practice to provide the opportunity for pain medication for all clients 
complaining of pain even when there is no diagnostic evidence to support their complaint. This is 
because it is difficult to make an absolute conclusion when drug-seeking is suspected and if a 
client presents with pain symptoms it is challenging to deny pain medication. The results from 
the research show that there is evidence that specific behaviors associated with drug-seeking can 

















 Drug-seeking is not a recent phenomenon but is an ever present obstacle seen in EDs 
throughout the world. Prescription drugs have become the second most common abused drug in 
the United States which as lead to an influx in drug-seekers in the ED (Wilsey, Fishman, Ogden, 
Tsodikov, & Bertakis, 2008a). There has not yet been enough research to identify an evidence-
based and effective solution for managing drug-seekers in the ED. However, the included 
research shows a variety of ways to identify drug-seekers. In an effort to reduce future 
prescription drug abuse, research to identify drug-seeking behavior is vital. In this integrative 
literature review twelve research articles were analyzed to identify the most common drug-
seeking behaviors and the potential methods for managing drug-seekers. The included articles 
reported the following approaches to help identify drug-seekers: proper assessment, drug 
screening, and prescription monitoring systems.    
Assessment  
Eight articles indicated that drug-seeking behavior can frequently be identified through 
the use of proper assessment tools and standardized client assessment. The assessment tools 
utilized demographic information with various scales and surveys constructed specifically to 
identify drug abusers. The combination of; exceptional assessment skills, evidenced based 
evaluation tools, common behaviors, signs and symptoms of substance abuse and objective 
information can help identify drug-seekers and offer an opportunity to provide appropriate care.  
An Australian study showed a correlation between drug-seeking and identifying a drug of 
choice or reporting an allergy to pain medications by using a convenience sample of 37 
participants. A questionnaire was developed that focused on nine subcategories including: client 
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demographics, triage category, chief complaint, psychiatric disorder, request for prescription, 
past medical history and record of visits, any previously suspected drug-seeking, allergies to 
medications, medications sought by clients, medication administered in the ED, diagnostic 
procedures implemented, and disposition details (Schuckman, et al., 2008).  
The questionnaire was filled out by the physician when he or she suspected a client of 
drug-seeking. The results showed 11% of the participants reported an allergy to morphine, 
codeine, and non-steroidal anti-inflammatory drugs (NSAIDs). Furthermore, nearly 90% of the 
clients suspected of drug-seeking indicated a drug of choice. Out of the 37 clients suspected of 
drug-seeking, 81% requested a narcotic drug and 8% requested a benzodiazepine. Over half of 
the clients (62%) reported a primary complaint of abdominal, back, chest, head, or neck pain. 
Over one-third (38%) of the subjects had been seen multiple times in the ED; whereas, only 2% 
of the subjects were diagnosed with a new organic disorder (McNabb, et al., 2006).  
The data obtained from this study supported the theory that drug-seekers are likely to 
report a drug of choice and/or state allergies to medication in order to obtain a drug of choice, 
and visit several EDs on multiple occasions in order to support their addiction. This research also 
shows that ED staff has a tendency to categorize psychiatric clients as drug-seekers and 
psychiatric screenings should be completed when drug-seeking is suspected. Overall, the 
findings in this study clearly provided the information that the researchers indented to find. The 
aim of this study was to identify commonalities among clinical presentations where physicians 
suspect drug-seeking behaviors (McNabb, et al., 2006).  
This study was limited by a small sample size and the use of only one facility located in a 
large metropolitan area. In order for this research to be utilized in a developing a way to screen 
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clients suspected of drug-seeking in the ED a larger study will need to be conducted in multiply 
ED locations and participants should be obtained through randomized sampling. This 
preliminary study provides a base for developing a larger scale experiment that will help to 
define the characteristics of a tool that can be utilized in the ED to screen clients suspected of 
drug-seeking (McNabb, et al., 2006).  
In a much larger study, de-identified medical records of 632,000 privately insured 
residents were analyzed for commonalities among substance abusers. A client was considered a 
substance abuser based on the number of opioid prescriptions issued within one year (White, et 
al., 2009). The results indicated that those suspected of prescription opioid abuse were 
predominately male between 25 and 34 years of age. Behavioral characteristics associated with 
abuse were filling prescriptions at two or more pharmacies, having one or more early refills, and 
demonstrating two or more consecutive months of dose escalation. This study shows the 
feasibility in developing an algorithm that can be utilized to identify common behaviors and 
biographical information among drug abusers in order to incorporate that information into 
developing a screening tool to identify drug-seekers in the ED (White, et al., 2009). It also shows 
how insurance companies may be able to partner with ED providers to help identify and prevent 
prescription opioid abuse.  
A study was completed to develop a tool to identify substance abusers called the Current 
Opioid Misuse Measurement (COMM, 2009) scale. The COMM was developed by a team of 26 
pain management specialists, addiction experts, and primary care providers dedicated to 
constructing a clinical tool that could be used to screen the chronic pain population for 
prescription drug abuse. The COMM is a 42 question assessment tool comprised of statements 
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that were developed through intergrading six subcategories, including: signs and symptoms of 
misuse, emotional problems or psychiatric issues, poor response to medication, evidence of lying 
and drug use, medication misuse and noncompliance, and appointment patterns. The COMM 
focused on uncovering the truth by administering a subjective questionnaire with statements to 
be rated on a scale of 0-4 by the suspected prescription abuser (Butler, et al., 2007).  
The first trial of 200 subjects participated in a week long study in which the results of the 
COMM were compared to the results of a urinalysis. Initial results showed the instrument was 
helpful in identifying chronic pain clients with a prescription misuse problem. Further analysis 
identified 40 items as being relevant and 17 as being more likely to identify a client currently 
abusing prescription medications.  Although the COMM may be useful in the ED setting, 
researchers constructed this tool to be used for the chronic pain population with a current pain 
management regimen (Butler, et al., 2007).  
A later analysis of the COMM was completed by a group of researchers working to 
establish an assessment tool that would help to identify prescription drug abusers not currently 
under supervision of a primary care physician. A team of seven researchers affiliated with the 
Clinical Addiction Research and Education (CARE) Unit of Boston Medical Center and Boston 
University School of Medicine approached 2,194 clients in the safety-net hospitals. The 
participants observed in this study had to meet the following inclusion criteria: 18–60 years of 
age, English speaking, have suffered from chronic pain for at least the past three months, 
reported use of analgesic medication within the past month, and had at least one prescription for 
an opioid in the year prior to the study. Out of the 2,194 clients interviewed only 238 met the 
inclusion criteria and agreed to participate in the study (Meltzer et al., 2010).  
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Their goal was to identify participants suffering from a substance abuse disorder by 
administering a shorter version of the COMM using the 17 questions determined to be more 
effective. During the interview portion of the study, each participant was administered the 
COMM in which the following key variables were examined: sociodemographic factors, income, 
level of education,  marital status, health insurance, presence of  a major depressive disorder, 
family history of substance abuse disorder (SUD), and current use of tobacco products. The 
results indicated that 11% of the participants currently had prescription drug abuse disorder 
(PDD) and 7% of the participants currently had substance use disorder (SUD). Although the 
remaining 8% had no disorder, 24% of these participants previously had PDD or SUD (Meltzer, 
et al., 2010).  
In order to support the reliability of the COMM the results were subjected to a parametric 
analysis of variance (ANOVA) and nonparametric analyses (Kruskal–Wallis) which indicated 
the same significant results. Participants with PDD were more likely to be female, African-
American, have a lower level of education, have some form of major depressive disorder, use 
tobacco products, have alcohol dependence, and be on some form of disability (Meltzer, et al., 
2010).  
 Results of this study support that clients with PDD and/or SUD can be identified using a 
shorter assessment tool. The shorter COMM (17 questions) may be more appropriate for use in 
settings with great time constraints such as the ED. The instrument, however, was only evaluated 
in a primary care setting. Although participants were approached in a hospital setting they were 
later interviewed in a primary care setting by physicians, master’s degree-level professionals, 
college graduates, and college students who underwent over 60 hours of interview training 
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(Meltzer, et al., 2010). In order to make this research more applicable for emergency care 
professionals, additional research would need to be conducted solely in an ED setting.  
 A separate randomized trial reported similar results by interviewing clients with chronic 
back and neck pain (Jamison et al., 2010). This study was conducted in an effort to identify 
potential for opioid misuse by six researchers affiliated with the Pain Management Center and 
Harvard Medical School. The sample consisted of participants that met the following inclusion 
criteria: suffering from chronic back or neck pain, currently using prescribed long-acting opioids 
for pain for more than six months, show no signs of medication misuse, have an average score of 
4 or greater on the 0-10 pain scale, English speaking, and have a risk for substance abuse 
indicated by a score of six or higher on the Screener for Opioid Abuse for Pain Patients 
(SOAPP). A total of 62 participants were recruited to take part in a six month trial and received a 
comprehensive physical and history exam by a physician prior to the study. The physician 
reviewed their pain management therapy which all participants were required to adhere to 
throughout the study. Participants were subdivided into three randomized groups based on their 
SOAPP score. The three groups were placed into a high-risk control group, a high-risk 
experimental group, or a low-risk experimental group.   
The high risk and low risk experimental groups each had to complete a monthly 
electronic diary; whereas, the high risk control group was required to complete a monthly 
electronic diary, urinalysis, and attend compliance counseling. Each group was required to 
complete a pre-treatment and post treatment assessment including completing the following 
questionnaires: The Brief Pain Inventory (BPI), The Hospital Anxiety and Depression Scale 
(HADS), and The Pain Disability Index (PDI). Surprisingly the HADS assessment showed 
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similar scores for all three groups indicating that anxiety and depression do not significantly 
affect the risk for substance abuse. However, the BPI and the PDI assessments showed a 
significant difference among the three groups, which was a correlation between a greater severity 
of debilitating pain and an increased risk of developing substance misuse. The high-risk control 
group was 50% more likely to abuse substances than the high-risk and low-risk experimental 
groups (Jamison, et al., 2010).  
The Prescription Drug Use Questionnaire (PDUQ) is among the most well-developed 
substance abuse evaluation method for pain clients at this time (Jamison, et al., 2010; Meltzer, et 
al., 2010). It is comprised of 42 questions and is to be administered by a clinician to the client. 
The PDUQ is utilized to assess the client’s pain condition, opioid use patterns, social and family 
factors, family history of pain and substance abuse, and psychiatric history. According to the 
guidelines, a score greater than 11 on the PDUQ is considered a positive indicator for the Drug 
Misuse Index. The Addiction Behaviors Checklist (ABC) is a 20 item assessment tool that was 
designed to identify key behaviors that are associated with addiction to prescription opioid 
medications commonly seen in the chronic pain populations. The assessment is comprised of 
“yes” and “no” statements and completed by a physician (i.e. the client ran out of prescription 
medication before indicated by the dosage); therefore, the assessment is focused on objective 
information. If a client scores a three or higher on the ABC the client is considered to be 
displaying inappropriate prescription drug use. The Drug Misuse Index (DMI) is determined by a 
positive score on the PDUQ, the ABC, and the urine toxicology results (Jamison, et al., 2010).  
The results of this study showed 32% of the participants scored an eleven or higher on the 
PDUQ; whereas, only 16% of the participants scored a three or higher on the ABC. Urine 
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toxicology screenings showed that 19% of the participants had used marijuana or additional 
opioids that were not prescribed. Overall, 39% of the participants were positive for the DMI 
which was reflected by their PDUQ answers, ABC evaluation, and a positive urinalysis. Almost 
75% of the high-risk experimental group scored a positive result on the DMI; whereas, a little 
over 25% of the high-risk control group and the low-risk experimental group received a positive 
score on the DMI (Jamison, et al., 2010). 
The assessment tools utilized in this study helped to objectively and subjectively identify 
chronic pain clients that were abusing their prescription medications. Participants also indicated 
that they felt the study helped them to remain complaint with their pain regimen.  
Although this study was conducted over a long period of time, the data may be useful to 
help construct an assessment tool that can be implemented in an ED setting. As seen in this 
study, many of the participants suffering from chronic pain and using prescription opioids were 
at a higher risk for developing an addiction to prescription substances which supports the theory 
that a large percentage of drug-seekers in the ED are more than likely suffering from chronic 
pain and an addiction to prescription medication (Jamison, et al., 2010).  
The limitations of this study included a small sample size, a high propensity for loss of 
subjects due to the requirements to complete the study, and an abundance of data to be collected 
and analyzed which may have lead to erroneous results. In order to make the evidence collected 
in this study more pertinent to application in emergency medicine additional research needs to be 
completed in an ED setting.  
In a study conducted in Sacramento, California 113 clients visiting the ED and Urgent 
Care Centers were recruited to participate in a study that used the following evaluations: the 
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SOAPP, BPI, HADS, PDI, the Spielberg State-Trait Anxiety Inventory (STAI), and the 
Personality Diagnostic Questionnaire (Wilsey, et al., 2008b). This study sought to identify 
psychological cormobidities associated with drug-seeking in the ED.  Of the 113 participants 
interviewed, 81% showed positive signs for a propensity for prescription drug abuse, 59% of the 
participants were within the range for clinical depression, 39% met the criteria for a state of 
anxiety, 34% of the participants also met the requirements for post traumatic stress disorder 
(PTSD), and over half of the participants were likely to have a personality disorder (Wilsey et 
al., 2008b).  
Drug Screening 
 Another tool to aid in identifying drug-seekers is drug screening. The quickest, most 
effective, way to discover what drugs are in a clients system is by simply implementing a 
urinalysis (Ives et al., 2006). Tests using blood, hair, saliva, or sweat are also available. 
However, the most commonly exercised is a simple urinalysis (Schuckman, et al., 2008). Several 
articles researched the validity of using drug screening as a tool for identifying substance 
abusers. 
Summa Health System researchers focused on self-report of drug use in comparison with 
the results of a urinalysis in an effort to establish a base line of underreporting of substance abuse 
in the ED. A retrospective study of 248 clients meeting the inclusion criteria and treated at a 
university-affiliated hospital in the Ohio area was conducted over a 6-year period. Subjects 
presented to the ED with a primary complaint of back pain, headache, or toothache.  Even 
though participants were aware of the drug screening, 33% of the 238 participants had positive 
results for unclaimed drugs. Participants with a history of drug abuse, that requested a specific 
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narcotic or with chronic pain were significantly more likely to test positive for unclaimed drugs. 
Of the 238 participants, 10% tested positive for cocaine, and 4% for opioids (Schuckman, et al., 
2008).  
Study results showed that self-report of substance abuse is unreliable and more objective 
measures may be required in order to identify drug-seekers. Further research is necessary due to 
the limitations associated with attempting to screen for drugs with a short half life that are 
expelled from the system quickly or cannot be detected in the urine. The limitations of this study 
also included an increased potential for non-compliance with drug screening due to the 
implications of testing positive for an unclaimed drug. Research using anonymous specimens 
may prove more beneficial (Schuckman, et al., 2008).  
 Findings in a prospective cohort study conducted in North Carolina focusing on clients in 
a chronic pain management program showed similar results. Participants were periodically 
screened over a 12 month period for medications not prescribed and/or concurrent illicit drug 
use. The participants were required to undergo a preliminary health and physical exam which 
included collecting biographical data, pain assessment, disability, temperament, level of 
education, and ability to complete required material. Of the 196 participants, 32% were positive 
for opioid misuse. Participants with chronic pain, a history of drug use, or previous legal 
complications as a result of alcohol or drug use were considerably more likely to have positive 
urinalysis (Ives, et al., 2006).  
 Both studies report that clients with chronic pain or a history of substance abuse are at a 
higher risk for denying the use of illegal substances. Furthermore, they agree that drug 
screenings have limitations due to the short half-lives of frequently abused substances. The 
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researchers also agree that it is necessary to implement drug screening when substance abuse is 
suspected because self report is an unreliable source of information (Schuckman, et al., 2008). 
Limitations to this study include, as with other studies, excludes participants with a history of 
psychiatric disorders limiting the available information on self report of clients with mental 
illness (Ives, et al., 2006).   
 A cross-sectional probability sample survey was conducted in 81 hospitals throughout the 
Tennessee area. The 1,502 participants meeting the inclusion criteria for the study were 
interviewed and provided a specimen for analysis. The results showed some similarity and 
significant differences to other studies in this review. Marijuana, benzodiazepines, and opioids 
are the most prevalent underreported substances abused. Researchers also found a predominance 
of substance abuse identified in 10% of females ages 65 and over which showed a propensity for 
abusing opiates, benzodiazepines, and stimulants (Rockett, Putnam, Jia, & Smith, 2006).  
The limitations of this study are similar to the previous two studies and include a variable 
window for detecting certain substances, limitations on compliance with drug screening, and the 
exclusion of participants with mental health problems. The results support the unreliability of 
self reports indicating a need for drug screening in the ED. A large number of participants were 
unwilling to provide a specimen to be analyzed. In this study it was also indicated that there is a 
risk of false positive results (Rockett, et al., 2006).  
Prescription Monitoring 
 Recently several states including Illinois, Minnesota, Ohio, Tennessee, and Virginia have 
been working to develop a statewide prescription monitoring program. A prescription monitoring 
program helps decrease hospital shopping, physician shopping, and filling prescriptions in 
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multiple pharmacies. When drug-seekers are identified and forced to limit the number of 
prescriptions they obtain it will hopefully lead to a decline in prescription drug abuse.  
 Ohio initiated a statewide prescription monitoring program in 2006, referred to as the 
Ohio Automated Rx Reporting System (OARRS). This system monitors the prescription drugs in 
schedules II, III, IV, and V, carisoprodol products, and tramadol products. Information is 
collected from pharmacies and distributors bi-weekly and made readily available to physicians, 
pharmacists, and law enforcement agencies. Information from more than 18 million prescriptions 
is distributed on the internet via encrypted files. The study conducted by the University of 
Toledo Medical Center ED used the information available through the OARRS to observe for 
changes in client care (i.e., medication, dose, and diagnosis) and what specific information lead 
to these decisions (Baehren, et al., 2009).  
Participants were adults with a chief complaint of dental, neck, back, head, joint, or 
abdominal pain not related to acute injury and/or trauma. Health care providers working in the 
Toledo Medical Center ED where given the opportunity to assess clients and make an educated 
clinical decision about the treatment they would provide. After the exam was completed a 
research assistant would administer a survey to assess what treatment they would provide, then 
given the information obtained through the OARRS system, after which they were given a 
follow up survey about how the data provided by the OARRS system changed their treatment 
method (Baehren, et al., 2009).  
Data analysis showed that ED providers were likely to alter their treatment plan based on 
the information provided by the OARRS system. In fact, opioid prescribing was altered for 41% 
of clients. When prescribing decisions changed, 61% of physicians were for reduced or no opioid 
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medication while 39% received a larger prescription. Common reasons for physicians altering 
opioid prescription practices were related to the number of previous prescriptions filled, the 
number of physicians writing prescriptions, the number of pharmacies filling prescriptions, and 
the number of addresses listed for the client (Baehren, et al., 2009). 
The information provided by this study showed that a prescription monitoring program 
affects ED physician treatment plans. The OARRS provides information to health care providers 
that otherwise would only be obtained through self report which has been show to be unreliable. 
The most important study finding was not that physicians altered their treatment plan, but that in 
many cases, physicians saw that a client they suspected of drug-seeking was more than likely in 
pain (Baehren, et al., 2009). This study was limited to one facility and the information posted in 
the OARRS is reported to be delayed by almost three weeks (Baehren, et al., 2009). 
There are several limitations to implementing an effective prescription monitoring 
program, with the most obvious flaw being the difficulty of interstate monitoring. Without this 
feature, drug-seekers can simply circulate between states. In an effort to overcome this flaw, 
states have been working together to develop cooperative prescriptive monitoring. This would 
solve one problem but still leave the obstacle of overcoming regulations established by Health 
Insurance Portability and Accountability Act (HIPPA) (Baehren, et al., 2009). 
Summary 
 Overall, the findings showed evidence that drug-seeking can be identified in a variety of 
settings, including the ED. Identifying common drug-seeking behavior through assessment of the 
client by using proper evaluation tools is both possible and essential. In order to make educated 
decisions about drug-seekers in the ED objective assessments include drug screening and 
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prescription monitoring which have been proven to be effective tools for identifying substances 
abusers. Through this integrative literature review, a variety of methods have been shown to be 
effective for the use of identifying drug-seekers; however, they have not yet been well 




















 The purpose of this integrative review of literature was to identify common drug-seeking 
behaviors in the ED, identify previous research on the topic, and evaluate measurement tools for 
drug-seeking clients. Common drug-seeking behaviors include pain complaints that are difficult 
to objectively validate, hospital shopping, requesting or having allergies to specific medications, 
and having a psychological cormobidity. Several methods have been identified to adequately 
recognize the signs and symptoms associated with substance abuse in order to provide the proper 
care. The findings showed that assessment, drug screening, and prescription monitoring 
programs can help identify drug-seekers by focusing on the common behaviors associated with 
substance abuse.  
Assessment 
Eight of the research articles reviewed showed similar assessment tools can be utilized to 
identify drug-seekers in the ED. The evaluation devices most commonly used in the research 
included: the Addiction Behaviors Checklist (ABC), the Brief Pain Inventory (BPI), the Current 
Opioid Misuse Measurement (COMM), the Hospital Anxiety and Depression Scale (HADS), the 
Pain Disability Index (PDI), the Prescription Drug Use Questionnaire (PDUQ), and the Screener 
for Opioid Abuse for Pain Patients (SOAPP). The assessment tools utilized in this research were 
constructed specifically to identify drug abusers, and their use can be an effective way to 
recognize common signs and symptoms associated with drug-seeking (Jamison, et al., 2010; 
Meltzer, et al., 2010).  
It must be noted that none of the assessment tools has been evaluated in the ED setting. 
Time and other environmental constraints associated with the ED may change instrument 
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performance. Modified or condensed versions of existing instruments may be required for the 
ED setting (Meltzer, et al., 2010).  Furthermore, many of the instruments seen in this review 
were administered and interpreted by trained experts. In order for these assessment tools to be 
successfully implemented in the ED, practitioner training in both administration and 
interpretation may be required.  
Drug Screening  
 Implementing drug screenings has been shown to be an effective tool for identifying drug 
abusers. There are a variety of methods to administering a drug screening which require a 
biological specimen, such as blood, hair, urine, saliva, or sweat. However, the most commonly 
utilized method is a urinalysis. Of the articles reviewed, three focused on validity of use drug 
screening as a tool for identifying substance abusers. The information obtained showed 
conflicting results with self report and the results from a urinalysis, thus indicating that self 
report is an unreliable source of substance abuse history (Ives, et al., 2006; Rockett, et al., 2006; 
Schuckman, et al., 2008).  
 The research showed that the most unreliable reporters of substance abuse are clients 
with chronic pain, a history of substance abuse, or a history of legal complications associated 
with alcohol or drug use. The research suggested that tobacco users and clients with no history of 
substance abuse are among the most reliable of self reported use. The implementation of drug 
screening in the ED will help to identify substance abusers suspected of drug-seeking which will 
help to conserve resources and decrease expenditures (Ives, et al., 2006). Unfortunately, drug 
screening is only effective in identifying substances that remain in the body for a long period of 
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time showing that drug screening should be used in conjunction with additional tools to identify 
drug-seekers.  
 Other issues associated with implementing drug-screening in the ED are resource 
utilization, costs, and client privacy. Specimens for a urinalysis must be collected and sent to the 
hospital laboratory for analysis which increases both resource utilization and costs. There is also 
debate regarding client privacy rights and drug screening, unless the screening is medically or 
legally justifiable (Rockett, et al., 2006). Although an effective way to identify individuals who 
have recently used certain types of drugs, widespread use of urine drug screening requires more 
research and debate. 
Prescription Monitoring 
 As prescription substance abuse becomes more prevalent, government officials are 
attempting to address the problem by implement statewide prescription monitoring programs. 
Ohio developed a statewide prescription monitoring program referred to as the Ohio Automated 
Rx Recently Reporting System (OARRS). Shortly after the program was initiated researchers 
attempted to support the validity of the program by discovering if prescription monitoring affects 
the treatment provided by healthcare providers. The research reported that a successful 
prescription monitoring program has a direct effect on the treatment that physicians provide 
(Baehren, et al., 2009).  
 Although prescription monitoring has been shown to be an effective tool for helping 
physicians to make more informed decisions about providing medications, care must be taken to 
protect clients’ rights to privacy. Statewide monitoring programs are also ineffective at 
monitoring clients crossing state lines to hospital shop. Prescription monitoring is also 
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ineffective at identifying prescription drug abusers that obtain substances illegally (Baehren, et 
al., 2009).  
Summary 
 The research reviewed showed evidence regarding a variety of subjective and objective 
methods to identify drug-seeking behaviors in the ED. Drug screening is a more concrete method 
of discovering substance abuse but may be subjected to false positives or false negatives and 
cannot screen for drugs with a short half-life (Schuckman, et al., 2008). Resources available to 
help ascertain the true motive for a client can be identified through the use of prescription 
monitoring programs which provide information about the number of prescription a client has 
had, the physicians providing treatment, and the quantity of pharmacies that the client uses on a 
regular basis (Baehren, et al., 2009). Incorporating these resources together to indentify drug-












 Numerous limitations were noted in this integrative review of literature, including: small 
sample sizes, limited resources, inadequate training, and a limited amount of research conducted 
in EDs. In all but two of the studies reviewed sample size was limited to less than 250 
participants. In the majority of the studies participants were recruited through convenience 
sampling when studies utilizing randomized sampling show more statistically significant results. 
The resources for these studies were also limited to utilizing one to four facilities in a close 
proximity to each other. The majority of the research was completed outside of the ED.  
 An additional limitation seen with drug screening is a risk for skewed data from false 
positive or false negative results. There is also a limitation in screening for commonly abused 
drugs as they do not remain in a clients system for an extended period of time. Of the three 
studies conducted by Ives and colleges in 2006, Rockett and colleges in 2006, and Schuckman 
and colleges in 2008, there were also a high number of participants that refused to provide a 
specimen for analysis even though they were instructed prior to beginning the study that they 
would be required to while taking part in a drug screening (Ives, et al., 2006; Rockett, et al., 
2006; Schuckman, et al., 2008).  
 Limitations specific to prescription monitoring were also identified. Prescription 
monitoring is necessary to screen for prescription drug abuse but is questionable to whether or 
not HIPPA laws are being broken. It is important for client rights to be protected even if that 
means that prescription monitoring cannot be continued. Limitations are also noted with 
implementing statewide prescription monitoring programs because it does not provide a way to 
monitor clients living on state lines where hospital shopping can cross state boarders.  
31 
 
RECOMMENDATIONS FOR NURSING 
Research 
 A variety of research has been conducted to facilitate a specific means of identifying 
substance abusers. Unfortunately, most of the research completed is unique making comparing 
results difficult. Additional research will need to be preformed based off of the research that has 
been completed in order to identify trends, similarities, and accumulate additional evidence to 
support the established theories about drug-seeking.  
This integrative review of literature may promote further investigation into the topic 
identifying drug-seeking behaviors in the ED. An area of immediate need is a valid and reliable 
assessment tool that takes into consideration the uniqueness and limitations of the ED setting. 
This may start with modifying instruments validated in primary care settings to function 
effectively in the ED environment. Further research should examine additional signs and 
symptoms that have not yet been recognized.   
When performing future studies, it would be favorable for researchers to use a sample 
size based on a power analysis to optimize the likelihood of detecting any differences if they 
exist. Random sampling representative of the population will improve external validity and 
generalizability of any results. Additional studies conducted incorporating more rigid standards 
will help to produce more accurate and empirically valid evidence.  
Education 
Nurses must be educated regarding the impact that drug-seeking on the available 
resources in the ED. Nurses should also receive education on proper management of clients 
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suspected of drug-seeking, such as referral services, drug rehab centers, and available 
alternatives to seeking care in the ED.  
Practitioners should be educated about the available information from state wide 
prescription monitoring programs and how to utilize the data when providing care. It is also 
important for care providers to understand the limitations of drug screening and the implications 
associated with administering a urinalysis, such as: cost, time constraints, and client rights. 
Educating ED staff about the tools available to identify-drug seekers is an important aspect of 
helping to provide effective pain management in the ED. 
It is imperative that nurses also educate their clients about the risk factors associated with 
substance abuse so that they can try to recognize what factors may make them more susceptible 
to addiction. Clients suspected of drug-seeking should be educated about the variety of resources 
available to help them recover from addiction. Nurses must also provide family education about 
the risk factors for developing substance abuse and the signs and symptoms of substance abuse 
so that they will be more capable of identifying drug-seeking behavior in their family member.   
Practice 
 The results from this integrative review of literature have many implications for practice 
in the emergency medical field. At present, no assessment tool has been validated and 
successfully implemented in the ED. It is important for nurses to be aware of drug-seeking in the 
ED and make the appropriate decisions in accordance with their facilities protocols while acting 
as a client advocate.  
 When a practitioner’s assessment leads to concern that a client may be drug-seeking, a 
thorough review of available medical history along with other available information (e.g., drug 
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screen) is warranted. Signs and symptoms such as frequent ED visits for pain, a history of 
substance abuse, or a record of allergies to specific non-narcotic pain medications may support 
drug-seeing suspicions. Prescription monitoring as also been shown to be an effective tool to 
guide treatment provided. Providers can utilize the information obtained by prescription 
monitoring programs to provide effective pain management in the ED.  
 A nurse’s primary concern should always be centered on the comfort and well-being of 
their client. The nurse is the client advocate and must work to ensure the client is receiving 
proper care. That is why it is essential for a client to receive a comprehensive assessment 
including physical, history, and drug screening when indicated. The research shows that there is 
no single assessment tool to identify drug-seeking behaviors in the ED. However, practitioners 
using valid assessment tools, drug screening, and prescription monitoring may be able to more 













Baehren, D. F., Marco, C. A., Droz, D. E., Sinha, S., Callan, E. M., & Akpunonu, P. (2009). A 
statewide prescription monitoring program affects emergency department prescribing 
behaviors. Annals of Emergency Medicine, 56(1), 19-23.  
Butler, S. F., Budman, S. H., Fernandez, K. C., Houle, B., Benoit, C., & Katz, N. (2007). 
Development and validation of the Current Opioid Misuse Measure. Pain, 130(1-2), 144-
156.  
Chan, L., & Winegard, B. (2007). Attributes and behaviors associated with opioid seeking in the 
emergency department. Journal Of Opioid Management, 3(5), 244-248.  
Hansen, G. R. (2005). The drug-seeking patient in the emergency room. Emergency Medicine 
Clinics Of North America, 23(2), 349-365.  
Hawkins, S. C., Smeeks, F., & Hamel, J. (2008). Emergency management of chronic pain and 
drug-seeking behavior: an alternate perspective. The Journal Of Emergency Medicine, 
34(2), 125-129.  
Ives, T. J., Chelminski, P. R., Hammett-Stabler, C. A., Malone, R. M., Perhac, J. S., & Potisek, 
N. M. (2006). Predictors of opioid misuse in patients with chronic pain: a prospective 
cohort study. BMC Health Services Research, 6, 46-46.  
Jamison, R. N., Ross, E. L., Michna, E., Chen, L. Q., Holcomb, C., & Wasan, A. D. (2010). 
Substance misuse treatment for high-risk chronic pain patients on opioid therapy: A 
randomized trial. Pain, 150(3), 390-400.  
35 
 
Kelleher, S., & Cotter, P. (2009). A descriptive study on emergency department doctors' and 
nurses' knowledge and attitudes concerning substance use and substance users. 
International Emergency Nursing, 17(1), 3-14.  
McNabb, C., Foot, C., Ting, J., Breeze, K., & Stickley, M. (2006). Profiling patients suspected of 
drug seeking in an adult emergency department. Emergency Medicine Australasia: EMA, 
18(2), 131-137.  
Meltzer, E. C., Rybin, D., Saitz, R., Samet, J. H., Schwartz, S. L., & Butler, S. F. (2010). 
Identifying prescription opioid use disorder in primary care: Diagnostic characteristics of 
the Current Opioid Misuse Measure (COMM). Pain, 152(2), 397-402.  
Rockett, I. R. H., Putnam, S. L., Jia, H., & Smith, G. S. (2006). Declared and undeclared 
substance use among emergency department patients: a population-based study. 
Addiction (Abingdon, England), 101(5), 706-712.  
Schuckman, H., Hazelett, S., Powell, C., & Steer, S. (2008). A validation of self-reported 
substance use with biochemical testing among patients presenting to the emergency 
department seeking treatment for backache, headache, and toothache. Substance Use & 
Misuse, 43(5), 589-595.  
Silka, P. A., Roth, M. M., Moreno, G., Merrill, L., & Geiderman, J. M. (2004). Pain scores 
improve analgesic administration patterns for trauma patients in the emergency 
department. Academic emergency medicine : official journal of the Society for Academic 
Emergency Medicine, 11(3), 264-270.  
Thomas, T. (2007). Providing pain relief for patients in the emergency department. Nursing 
Standard, 22(9), 41-45.  
36 
 
Todd, K. H., Ducharme, J., Choiniere, M., Crandall, C. S., Fosnocht, D. E., & Homel, P. (2007). 
Pain in the emergency department: results of the Pain and Emergency Medicine Initiative 
(PEMI) multicenter study. Journal of Pain, 8(6), 460-466.  
White, A. G., Birnbaum, H. G., Schiller, M., Tang, J., & Katz, N. P. (2009). Analytic models to 
identify patients at risk for prescription opioid abuse. The American Journal Of Managed 
Care, 15(12), 897-906.  
Wilsey, B. L., Fishman, S. M., Tsodikov, A., Ogden, C., Symreng, I., & Ernst, A. (2008b). 
Psychological comorbidities predicting prescription opioid abuse among patients in 
chronic pain presenting to the emergency department. Pain Medicine (Malden, Mass.), 
9(8), 1107-1117.  
 
 
